172 devices · GMDN 30516
Amphetamine-specific IVD kits use rapid immunochromatographic tests (ICT) to detect amphetamine presence in clinical samples like urine or blood within minutes. These point-of-care or lab-adjacent tests provide quick results for clinical decision-making, such as screening for substance use or monitoring treatment compliance.
These devices are typically regulated as in vitro diagnostics (IVDs) and may require validation for accuracy, sensitivity, and specificity. They are often supplied as ready-to-use kits, including reagents, controls, and instructions for immediate testing in clinical or emergency settings.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.